Biohaven Pharma (BHVN) Misses Q3 EPS by 4c

Biohaven Pharma (NYSE: BHVN) reported Q3 EPS of ($1.74), $0.04 worse than the analyst estimate of ($1.70).

For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.

You May Also Be Interested In

• Huang and Altman to attend Trump-Xi state dinner - ABC
• Oregon Bancorp, Inc. (ORBN) Declares $0.20 Quarterly Dividend; 2% Yield
• SpaceX: targeting to launch Starship flight 14 early as Sep 28